CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
57.33
+0.73 (1.29%)
At close: Aug 13, 2025, 4:00 PM
58.74
+1.41 (2.46%)
After-hours: Aug 13, 2025, 7:58 PM EDT
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$96,819
Profits / Employee
-$1,190,326
Market Cap
5.21B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRSP News
- 9 days ago - CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big - Seeking Alpha
- 4 weeks ago - Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade) - Seeking Alpha
- 6 weeks ago - CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline - GlobeNewsWire
- 2 months ago - Crispr Therapeutics: Betting On A One-Shot Future - Seeking Alpha
- 2 months ago - CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript) - Seeking Alpha
- 2 months ago - CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire